Söndag 18 Maj | 06:43:04 Europe / Stockholm

Prenumeration

2025-05-16 15:03:00

ZymIQ enters the next phase...

We have now accumulated solid knowledge of the needs of the market for the various product areas and have begun to focus more on selling and delivering unique enzyme-based products for humans and animal welfare.

All of our products that are now on the market represent a paradigm shift with new and advanced enzyme technology. We now notice that customers and consumers have opened their eyes to these unique news and sales are increasing even from low levels at the rate we predicted.

"Our platform with different business models tied to different segments and concepts will generate the expected leverage as soon as all the pieces of the puzzle have fallen into place"
Michael Edelborg Christensen
CEO ZymIQ Technology

1 Jan – 31 March 2025

  • Net sales amounted to SEK 812 thousand (416)
  • Loss after tax amounted to SEK -2,063 thousand (-2,179)
  • Earnings per share amounted to SEK -0.24 (–0.30)
  • Cash and cash equivalents amounted to SEK 2,257 thousand (724)

Significant events during the reporting period

  • Kalzyme™ has participated in Sweden's largest dog fair, MyDog in Gothenburg
  • The issue ended 28/3 2025
  • ZymIQ Biopharma participated in AMR Conferense in Basel
  • ZymIQ's enzyme technology has been shown to be effective against difficult-to-treat mycobacteria in a preclinical in vivo study
  • Kalzyme™ has received its first order in Thailand
  • Kalzyme™ K9 Dental Spray has been added to the™ CombatClean product portfolio
  • ZymIQ has sent out its first press releases via the portal MFN
  • CombatClean™ has secured the first orders within NATO after attending the Enforce Tac - Law Enforcement and Defence Fair in Nuremberg, Germany
  • Kalzyme has been launched in Denmark and strengthened its presence in Sweden via VetApotek
  • Fjör™ has launched a new body moisturizer

Significant events after the reporting period

  • Kalzyme™ and the local distributor, the Floof Company, have participated in the PetExpo trade fair in Singapore
  • “Börsvärlden” follows ZymIQ in three different articles in 2025
  • Two more Fjör products are fully formulated
  • Evaluation of Clean Teeth Enzyme Tab together with Nässjö municipality's elderly care has been completed
  • New sale of Clean Teeth Enzyme Tab for soldiers and Kalzyme™ K9 for military service dogs to Hungary


Every care has been taken in the translation of this Financial Report. In the event of discrepancies,
the Swedish original will supersede the English translation